We used real-time reverse-transcription polymerase chain reaction (RT-PCR) to assay expression of the
mRNA of
thymidylate synthase (TS) and
dihydropyrimidine dehydrogenase (DPD) in
gastric cancer tissue with the objective of establishing a system to measure TS and DPD in ultra-low-volume samples. Nude mouse xenografts of 5 human
gastric cancer cell lines and 85 clinical samples were used as the specimens in this study. Sensitivity to
5-fluorouracil (5-FU) was determined on the basis of the relative
tumor proliferation rate in mice and the results of
ATP assay using serum-free cultures of the clinical samples.
mRNA expression was measured in
tumor tissue by real-time RT-PCR using the ABI PRISM 7700 system. The values for expression of the
mRNA for TS and DPD were corrected according to the level of
glyceraldehyde-3-phosphate dehydrogenase mRNA expression. The xenografts yielded correlations between TS and DPD
mRNA expression and the activity of the
enzymes (TS: rs=0.700, DPD: rs=0.900), and an inverse correlation was noted between the
mRNA levels and sensitivity to
5-FU (TS: rs=-0.900, DPD: rs=-0.800). The clinical samples showed an inverse correlation between
5-FU sensitivity and
mRNA expression (TS: rs=-0.518, DPD: rs=-0.564). Sensitivity to
5-FU was noted only in cases in which TS
mRNA expression and DPD
mRNA expression were both low. Real-time RT-PCR can provide a highly sensitive assessment of TS and DPD
mRNA expression in
gastric cancer, and it was useful for predicting
5-FU sensitivity.